Sikic; Branimir

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sikic; Branimir.The latest application filed is for "protein modulators of resistance to alkylating agents".

Company Profile

0.1.12

Sikic; Branimir - Stanford CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Protein modulators of resistance to alkylating agents Grant 7,875,274 - Sikic , et al. January 25, 2	2011-01-25
Protein modulators of resistance to alkylating agents App 20070148145 - Sikic; Branimir ; et al.	2007-06-28
Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar App 20070009531 - Sikic; Branimir ; et al.	2007-01-11
Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanism App 20070009533 - Sikic; Branimir ; et al.	2007-01-11
Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanism App 20070009535 - Sikic; Branimir ; et al.	2007-01-11
Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar App 20070009532 - Sikic; Branimir ; et al.	2007-01-11
Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanism App 20070009534 - Sikic; Branimir ; et al.	2007-01-11
Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins App 20070010486 - Schwegman; Jeff ; et al.	2007-01-11
Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins App 20070010485 - Schwegman; Jeff ; et al.	2007-01-11
Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins App 20070010487 - Schwegman; Jeff ; et al.	2007-01-11
Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer App 20070010465 - Sikic; Branimir ; et al.	2007-01-11
Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer App 20070010478 - Sikic; Branimir ; et al.	2007-01-11
Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer App 20070010466 - Sikic; Branimir ; et al.	2007-01-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.